✦ LIBER ✦

Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy

✍ Scribed by Espirito Santo, Ana; Medeiros, Rui

Book ID: 126836785
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 451 KB
Volume: 9
Category: Article
ISSN: 1742-5255
DOI: 10.1517/17425255.2013.835803

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccine therapies for Non-Hodgkin’s Lymp

Vaccine therapies for Non-Hodgkin’s Lymphoma

✍ John M. Timmerman 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 511 KB

Therapy of non-Hodgkin's lymphoma

✍ J. Coffey; D. C. Hodgson; M. K. Gospodarowicz 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 160 KB

Treatment Approaches and Nursing Conside

Treatment Approaches and Nursing Considerations For Non-Hodgkin’s Lymphoma

✍ Jennifer Long; Linda Versea 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Interferon therapy of non-Hodgkin's lymp

Interferon therapy of non-Hodgkin's lymphoma

✍ Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar

Prospects for Immunotoxin Therapy of Non

Prospects for Immunotoxin Therapy of Non-Hodgkin's Lymphoma

✍ Michael L. Grossbard; Panos Fidias 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 599 KB

History of antibody therapy for non-Hodg

History of antibody therapy for non-Hodgkin’s lymphoma

✍ Andres Forero; Albert F LoBuglio 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 82 KB